Oligos & Peptides Formulation & Process Development

The inaugural Oligos & Peptides Formulation & Process Development Summit is the industry’s first forum bringing together experts addressing challenges and seek solutions to help to expedite drug discovery to scalable, GMP manufacturing for this new frontier of medicines!

Recently, Biogen’s announcement of $60m upfront investment on a new antisense candidate from Ionis, and Janssen’s strategic collaboration with i2O Therapeutics for macromolecules, demonstrated drug developers’ interest in next generation complex oligonucleotides and peptides have reached unprecedented level.

With the emergence of liquid phase synthesis technologies, improved bioavailability, and delivery approaches of oligos and peptides, drug developers realize the therapeutic potential of this 2nd generation of macromolecules can go beyond rare diseases with commercial viability.

Join 60+ of your peers and be part of this growing community. Featuring exclusive presentations, hands-on workshops, hours of networking from 18+ oligo and peptide thought-leaders, this summit will share exclusive insights on:

QbD for winning formula to optimize process development for complex oligos & peptides’

Synthesis strategies to improve stability of DS and DP

Updates on regulatory and CMC compliance

Seamless scale-up and tech transfer in collaboration with your CDMO partners